Purple Biotech (PPBT) Enterprise Value (QoQ) (2014 - 2026)
Purple Biotech (PPBT) Enterprise Value (QoQ) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - |
| 10 | Purple Biotech | 127.07 | 127.07 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 32.66% |
| Dec 31, 2025 | 7.52% |
| Sep 30, 2025 | -87.64% |
| Jun 30, 2025 | 15.54% |
| Mar 31, 2025 | 13.84% |
| Dec 31, 2024 | -22.39% |
| Sep 30, 2024 | 14.75% |
| Jun 30, 2024 | 32.09% |
| Mar 31, 2024 | 29.42% |
| Dec 31, 2023 | 3.64% |
| Sep 30, 2023 | 11.63% |
| Jun 30, 2023 | 20.66% |
| Mar 31, 2023 | -47.77% |
| Dec 31, 2022 | 53.53% |
| Sep 30, 2022 | 8.13% |
| Jun 30, 2022 | 8.95% |
| Mar 31, 2022 | 16.27% |
| Dec 31, 2021 | -3.69% |
| Sep 30, 2021 | 5.85% |
| Jun 30, 2021 | 12.79% |